{{Rsnum
|rsid=284875
|Gene=TGFBR3
|Chromosome=1
|position=91705151
|Orientation=plus
|GMAF=0.101
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=TGFBR3
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 4.6 | 95.4
| HCB | 2.3 | 50.0 | 47.7
| JPT | 0.0 | 15.6 | 84.4
| YRI | 1.6 | 17.5 | 81.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 2.3 | 50.0 | 47.7
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}

Part of a [[haplotype]] linked to [[stroke]] affecting perhaps 5% of [[sickle cell anemia]] patients

{{PMID|20401335|OA=1
}} Sickle Cell Disease in the Post Genomic Era: A Monogenic Disease with a Polygenic Phenotype.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}